Pub. Date : 2014 Mar
PMID : 24271646
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson"s disease. | opicapone | catechol-O-methyltransferase | Homo sapiens |
| 2 | PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson"s disease. | opicapone | catechol-O-methyltransferase | Homo sapiens |
| 3 | PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson"s disease. | opicapone | catechol-O-methyltransferase | Homo sapiens |
| 4 | PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson"s disease. | opicapone | catechol-O-methyltransferase | Homo sapiens |